Background: Ventilator-associated pneumonia (VAP) is the most common nosocomial infection in the intensive care unit and is associated with a high mortality rate.

Aim: The study was conducted to estimate the frequency, outcomes, and predictors of polymicrobial VAP.

Methods: A prospective observational study was conducted in mechanically ventilated adult patients in the medical intensive care unit in a tertiary care hospital in India from July 2016 to July 2018 with a 30-day follow-up period. The patients were grouped into monomicrobial and polymicrobial VAP. We compared the 30-day outcome parameters such as discharge from hospital, in-hospital stay, death, and complications such as catheter associated urinary tract infection (CAUTI), central line associated blood stream infection (CRBSI), bacteremia and collapse of lung. The predictors of polymicrobial VAP were identified by multiple logistic regression.

Results: Out of 301 patients clinically diagnosed with VAP, 151 patients were excluded, and the remaining 150 developed 186 episodes of VAP during the study period. The incidence of polymicrobial VAP was 62.9%. Out of 150 patients, 51 patients had monomicrobial VAP, and 99 had polymicrobial VAP. On univariate analysis, diabetes mellitus and poor sensorium (Glasgow Coma Scale [GCS] score <8) during endotracheal intubation; 30-day outcome, mean days of mechanical ventilation after VAP diagnosis and days in ICU; and CAUTI were significantly associated with polymicrobial VAP. On multivariable logistic regression, poor sensorium (GCS score <8) at the time of endotracheal intubation was an independent predictor of polymicrobial VAP.

Conclusion: The incidence of polymicrobial VAP is high in the medical ICU and is associated with increased duration of mechanical ventilation, hospital stay, and incidence of CAUTI. Poor GCS score was the single independent predictor of polymicrobial VAP.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860453PMC
http://dx.doi.org/10.2147/TCRM.S337341DOI Listing

Publication Analysis

Top Keywords

polymicrobial vap
16
poor sensorium
8
vap
8
intensive care
8
care unit
8
study conducted
8
predictors polymicrobial
8
polymicrobial
6
patients
6
sensorium time
4

Similar Publications

Polymyxin B Peptide Hydrogel Coating: A Novel Approach to Prevent Ventilator-Associated Pneumonia.

Int J Mol Sci

September 2024

Laboratory of Microbiology, Parasitology and Hygiene (LMPH), Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, Wilrijk, 2000 Antwerp, Belgium.

Article Synopsis
  • * This study introduces an antibacterial hydrogel coating utilizing polymyxin B (PMB) to inhibit bacterial adhesion, with thorough characterization of its properties and effectiveness against bacteria demonstrated over at least 8 days.
  • * The coating meets international cytocompatibility standards and shows potential for prolonged PMB release, laying the groundwork for future peptide-releasing formulations aimed at preventing VAP.
View Article and Find Full Text PDF

Tissue-Compatible and Lubricated Hydrogel Catheter with Promising Activity Against Polymicrobial Infections for Ventilator-Associated Pneumonia Prevention.

Adv Healthc Mater

December 2024

Key Laboratory of Soft Machines and Smart Devices of Zhejiang Province, Department of Engineering Mechanics, Zhejiang University, Hangzhou, 310027, China.

Article Synopsis
  • - Endotracheal intubation is crucial for critically ill patients but can lead to tissue damage and ventilator-associated pneumonia (VAP) due to biofilms created by drug-resistant pathogens.
  • - A new hydrogel catheter made from quaternary phosphonium salts is designed to be more tissue-friendly and prevent infections by inhibiting stubborn bacteria and fungi.
  • - This hydrogel displays strong antimicrobial properties, effectively killing most multi-drug resistant bacteria and fungi, and successfully prevents biofilm formation, thereby reducing the risk of VAP.
View Article and Find Full Text PDF
Article Synopsis
  • * A total of 103 adult patients with CRAB-related VAP were analyzed, comparing outcomes between those treated with dual and triple antibiotic combinations involving sulbactam.
  • * Results indicate that the triple therapy (sulbactam, polymyxin B, and minocycline) significantly reduced 28-day mortality and improved other health markers compared to the dual therapy, suggesting it may be a more effective treatment option.
View Article and Find Full Text PDF

Background: The 2016 IDSA guideline recommends a treatment duration of at least 7 days for hospital-acquired (HAP)/ventilator-associated pneumonia (VAP). The limited literature has demonstrated higher rates of recurrence for non-glucose fermenting gram-negative bacilli with short course therapy, raising the concern of optimal treatment duration for these pathogens. Therefore, we aimed to compare the outcomes for patients receiving shorter therapy treatment (≤ 8 days) versus longer regimen (> 8 days) for the treatment of multidrug resistant (MDR) Pseudomonas pneumonia.

View Article and Find Full Text PDF

Ventilator-associated pneumonia (VAP) is a critical hospital-acquired infection following non-cardiac surgeries, leading to poor outcomes. This study identifies VAP risk factors in non-cardiac surgical patients and determines the causative pathogens. A retrospective analysis with 1:4 propensity-score matching was conducted on patients in a surgical intensive care unit (ICU) from 2010 to 2020 at a private tertiary medical center.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!